# METRONIDAZOLE
> **ANDA216750** · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2024-12-31
## Drug
- **FDA Application Number:** ANDA216750
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** METRONIDAZOLE
- **Generic name:** METRONIDAZOLE
- **Active ingredients:** METRONIDAZOLE
- **Dosage form:** GEL
- **Route:** VAGINAL
- **Marketing status:** Prescription
- **Sponsor:** SCIEGEN PHARMS
- **Manufacturer:** Saptalis Pharmaceuticals LLC
- **First approval:** 2024-12-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216750)
---
*AI Analytics · CC0 1.0*